Evidence map›Paper›PMID 22825870›Full record

ArticleJournal of cell science2012

Role of Scd5, a protein phosphatase-1 targeting protein, in phosphoregulation of Sla1 during endocytosis.

Richard J Chi, Onaidy T Torres, Verónica A Segarra, Tanya Lansley, Ji Suk Chang, Thomas M Newpher, Sandra K Lemmon

Open access · greenAbstract read
In one paragraph

Article in Journal of cell science, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Richard J ChiDepartment of Molecular and Cellular Pharmacology, University of Miami Miller School of Medicine, FL 33136, USA.
Onaidy T Torres
Verónica A Segarra
Tanya Lansley
Ji Suk Chang
Thomas M Newpher
Sandra K Lemmon
University of Miami · US

Funding

SUPPRESSORS OF CLATHRIN DEFICIENCY IN YEASTR01GM055796 · NIGMS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI LEMMON, SANDRA K. · 1998 to 2015
$4.7M
TRAINING PROGRAMS IN CARDIOVASCULAR PHARMACOLOGYT32HL007188 · NHLBI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI SZCZESNA-CORDARY, DANUTA · 1985 to 2011
$3.8M
Phospho-regulation of Endocytosis by multifunctional PP1 targeting protein Scd5F32GM087900 · NIGMS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI CHI, RICHARD J · 2009 to 2010
$83k
NHLBI NIH HHS T32 HL007188NHLBI NIH HHS T32-HL007188NHLBI NIH HHS T32-HL07188NIGMS NIH HHS 5F32-GM087900NIGMS NIH HHS F32 GM087900NIGMS NIH HHS R01 GM055796NIGMS NIH HHS R01-GM055796
6 · The paper itself

Abstract

Phosphorylation regulates assembly and disassembly of proteins during endocytosis. In yeast, Prk1 and Ark1 phosphorylate factors after vesicle internalization leading to coat disassembly. Scd5, a protein phosphatase-1 (PP1)-targeting subunit, is proposed to regulate dephosphorylation of Prk1/Ark1 substrates to promote new rounds of endocytosis. In this study we analyzed scd5-PP1Δ2, a mutation causing impaired PP1 binding. scd5-PP1Δ2 caused hyperphosphorylation of several Prk1 endocytic targets. Live-cell imaging of 15 endocytic components in scd5-PP1Δ2 revealed that most factors arriving before the invagination/actin phase of endocytosis had delayed lifetimes. Severely affected were early factors and Sla2 (Hip1R homolog), whose lifetime was extended nearly fourfold. In contrast, the lifetime of Sla1, a Prk1 target, was extended less than twofold, but its cortical recruitment was significantly reduced. Delayed Sla2 dynamics caused by scd5-PP1Δ2 were suppressed by SLA1 overexpression. This was dependent on the LxxQxTG repeats (SR) of Sla1, which are phosphorylated by Prk1 and bind Pan1, another Prk1 target, in the dephosphorylated state. Without the SR, Sla1ΔSR was still recruited to the cell surface, but was less concentrated in cortical patches than Pan1. sla1ΔSR severely impaired endocytic progression, but this was partially suppressed by overexpression of LAS17, suggesting that without the SR region the SH3 region of Sla1 causes constitutive negative regulation of Las17 (WASp). These results demonstrate that Scd5/PP1 is important for recycling Prk1 targets to initiate new rounds of endocytosis and provide new mechanistic information on the role of the Sla1 SR domain in regulating progression to the invagination/actin phase of endocytosis.

Indexed as

Cytoskeletal ProteinsProtein Phosphatase 1Saccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsActinsBinding SitesClathrinEndocytosisGene Expression Regulation, FungalMutationPhosphorylationProtein BindingProtein Serine-Threonine KinasesProtein Structure, TertiaryWiskott-Aldrich Syndrome ProteinActinsARK1 protein, S cerevisiaeClathrinCytoskeletal ProteinsLAS17 protein, S cerevisiaePRK1 protein, S cerevisiaeProtein Phosphatase 1Protein Serine-Threonine KinasesSaccharomyces cerevisiae ProteinsSCD5 protein, S cerevisiaeSLA1 protein, S cerevisiaeSLA2 protein, S cerevisiaeWiskott-Aldrich Syndrome Protein

Identifiers

PMID22825870
PMCPMC3517093
OpenAlexW2139218845

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.